LPL Financial’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.24M Buy
39,732
+14,940
+60% +$871K ﹤0.01% 3393
2025
Q4
$1.47M Sell
24,792
-6,936
-22% -$378K ﹤0.01% 3683
2025
Q3
$1.72M Sell
31,728
-5,070
-14% -$290K ﹤0.01% 3459
2025
Q2
$2.02M Sell
36,798
-27,378
-43% -$1.61M ﹤0.01% 3108
2025
Q1
$4.54M Buy
64,176
+32,903
+105% +$2.21M ﹤0.01% 2233
2024
Q4
$2.06M Sell
31,273
-1,701
-5% -$114K ﹤0.01% 2838
2024
Q3
$2.32M Buy
32,974
+1,541
+5% +$129K ﹤0.01% 2582
2024
Q2
$2.59M Sell
31,433
-1,049
-3% -$87.3K ﹤0.01% 2381
2024
Q1
$2.84M Buy
32,482
+1,258
+4% +$113K ﹤0.01% 2232
2023
Q4
$3.01M Buy
31,224
+432
+1% +$38.2K ﹤0.01% 2076
2023
Q3
$2.72M Buy
30,792
+3,982
+15% +$354K ﹤0.01% 2050
2023
Q2
$2.32M Buy
26,810
+1,412
+6% +$133K ﹤0.01% 2114
2023
Q1
$2.47M Sell
25,398
-289
-1% -$30K ﹤0.01% 1976
2022
Q4
$2.66M Sell
25,687
-859
-3% -$80.6K ﹤0.01% 1862
2022
Q3
$2.25M Sell
26,546
-3,163
-11% -$282K ﹤0.01% 1886
2022
Q2
$2.46M Sell
29,709
-2,280
-7% -$182K ﹤0.01% 1874
2022
Q1
$2.47M Sell
31,989
-34,492
-52% -$2.89M ﹤0.01% 1892
2021
Q4
$5.88M Sell
66,481
-5,610
-8% -$463K ﹤0.01% 1356
2021
Q3
$5.57M Buy
72,091
+7,424
+11% +$586K 0.01% 1327
2021
Q2
$5.4M Sell
64,667
-8,082
-11% -$641K 0.01% 1292
2021
Q1
$5.49M Buy
72,749
+6,731
+10% +$550K 0.01% 1166
2020
Q4
$5.79M Buy
66,018
+17,994
+37% +$1.43M 0.01% 1038
2020
Q3
$3.65M Buy
48,024
+136
+0.3% +$13.8K 0.01% 1113
2020
Q2
$5.91M Buy
47,888
+4,045
+9% +$402K 0.01% 796
2020
Q1
$3.71M Buy
43,843
+5,059
+13% +$436K 0.01% 875
2019
Q4
$3.28M Sell
38,784
-1,322
-3% -$99.9K 0.01% 1056
2019
Q3
$2.7M Sell
40,106
-2,851
-7% -$220K 0.01% 1081
2019
Q2
$3.68M Buy
42,957
+8,547
+25% +$731K 0.01% 918
2019
Q1
$3.06M Buy
34,410
+4,404
+15% +$408K 0.01% 960
2018
Q4
$2.56M Buy
30,006
+1,263
+4% +$120K 0.01% 955
2018
Q3
$2.79M Sell
28,743
-781
-3% -$78K 0.01% 982
2018
Q2
$2.78M Buy
29,524
+19,790
+203% +$1.73M 0.01% 954
2018
Q1
$789K Sell
9,734
-2,624
-21% -$225K ﹤0.01% 1785
2017
Q4
$1.1M Sell
12,358
-1,393
-10% -$121K ﹤0.01% 1455
2017
Q3
$1.27M Buy
13,751
+203
+1% +$17.9K ﹤0.01% 1270
2017
Q2
$1.22M Buy
13,548
+10,216
+307% +$929K ﹤0.01% 1248
2017
Q1
$291K Buy
3,332
+750
+29% +$66.7K ﹤0.01% 2223
2016
Q4
$218K Buy
+2,582
New +$222K ﹤0.01% 2421
2016
Q2
Sell
-6,244
Closed -$518K 2654
2016
Q1
$518K Sell
6,244
-2,457
-28% -$200K ﹤0.01% 2134
2015
Q4
$901K Buy
8,701
+2,851
+49% +$298K ﹤0.01% 1762
2015
Q3
$641K Buy
5,850
+649
+12% +$86.7K ﹤0.01% 1573
2015
Q2
$727K Buy
5,201
+1,275
+32% +$158K ﹤0.01% 1598
2015
Q1
$475K Buy
3,926
+1,561
+66% +$165K ﹤0.01% 1885
2014
Q4
$214K Sell
2,365
-1,438
-38% -$120K ﹤0.01% 2455
2014
Q3
$268K Sell
3,803
-8,631
-69% -$567K ﹤0.01% 2259
2014
Q2
$774K Sell
12,434
-3,284
-21% -$198K ﹤0.01% 1505
2014
Q1
$1.07M Buy
15,718
+3,327
+27% +$245K 0.01% 1222
2013
Q4
$872K Buy
12,391
+5,438
+78% +$369K 0.01% 1329
2013
Q3
$473K Buy
+6,953
New +$462K ﹤0.01% 1695

Other funds holding BMRN